Ranked #1 Children's Hospital by U.S. News & World Report
MyPatients provides referring primary care providers with secure access to their patients’ information.
Boston Children's has launched the world's 1st program dedicated to offering hand transplants to children who qualify.
Innovation insider is a semi-monthly e-newsletter analyzes innovations at Boston Children’s, other academic medical centers and from industry.
Read the latest blog by a Boston Children's doctor, clinician or staff member.
Support the hospital with a donation that helps kids get the care they need.
Boston Children’s Hospital is the world’s largest research program at a pediatric institution, and we’re known for pioneering new treatments. A large part of our success comes from our commitment to research, which allows us to advance the field of transplantation through our innovative approach.
Our clinicians and investigators, who hold several prestigious honors, are responsible for many clinical and research firsts. Heung Bae Kim, MD, Surgical Director of the Pediatric Transplant Center, and Tom Jaksic, MD, PhD, Surgical Director of the Center for Advanced Intestinal Rehabilitation, developed the serial transverse enteroplasty, or STEP, procedure for short bowel syndrome (SBS).
The STEP procedure, which lengthens the bowel of children with SBS, may allow some children to wean completely from parenteral nutrition and avoid the need for intestinal transplantation. As of June 2009, Drs. Kim and Jaksic have performed 18 STEP procedures.
Children’s with short bowel or intestinal failure are typically unable to receive nutrition from food taken by mouth. For that reason, most are placed on parenteral nutrition (PN). With PN, the nutrients that the body needs to grow and develop bypass the normal digestive system and enter the patient directly through a thin tube inserted into a vein. But the prolonged use of PN often damages the liver, potentially leading to liver failure and the need for a transplant. Unfortunately, infants are at the greatest risk due to the small size of their livers. To minimize this risk, Children’s specialists have used a fish-oil derivative called Omegaven.
Heung Bae Kim, MD, surgical director of the Pediatric Transplant Center, and Tom Jaksic, MD, PhD, surgical director of CAIR, developed the serial transverse enteroplasty, or STEP, procedure for short bowel syndrome (SBS) in 2002. The STEP procedure, which lengthens the bowel of children with SBS, may allow some children to wean completely from parenteral nutrition and avoid the need for intestinal transplantation.
The future of pediatrics will be forged by thinking differently, breaking paradigms and joining together in a shared vision of tackling the toughest challenges before us.”